A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma
Status:
Terminated
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether P276-00 is safe and effective in treatment
of Mantle Cell Lymphoma that is recurred after or not responding to at least one previous
line of treatment.